2019
DOI: 10.1021/acs.jmedchem.9b00747
|View full text |Cite
|
Sign up to set email alerts
|

SAR Exploration of Tight-Binding Inhibitors of Influenza Virus PA Endonuclease

Abstract: Significant efforts have been reported on the development of influenza antivirals including inhibitors of the RNA-dependent RNA polymerase PA N-terminal (PAN) endonuclease. Based on recently identified, highly active metal-binding pharmacophores (MBPs) for PAN endonuclease inhibition, a fragment-based drug development campaign was pursued. Guided by coordination chemistry and structure-based drug design, MBP scaffolds were elaborated to improve activity and selectivity. Structure–activity relationships were es… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
62
1

Year Published

2020
2020
2024
2024

Publication Types

Select...
7
1

Relationship

3
5

Authors

Journals

citations
Cited by 36 publications
(66 citation statements)
references
References 39 publications
3
62
1
Order By: Relevance
“…In contrast, the removal of Zn II has been observed to destabilize the protein and results in a negative Δ T m (as seen with DPA) . It is important to note that while reported thermal shift data have revealed a good correlation between the observed IC 50 value and ▵ T m , this correlation has not been observed for inhibitors of NDM‐1 . In the case of the compounds tested here, ▵ T m did not correlate with IC 50 values.…”
Section: Resultscontrasting
confidence: 49%
“…In contrast, the removal of Zn II has been observed to destabilize the protein and results in a negative Δ T m (as seen with DPA) . It is important to note that while reported thermal shift data have revealed a good correlation between the observed IC 50 value and ▵ T m , this correlation has not been observed for inhibitors of NDM‐1 . In the case of the compounds tested here, ▵ T m did not correlate with IC 50 values.…”
Section: Resultscontrasting
confidence: 49%
“…47,48 The role of these enzymes in their respective diseases and inhibitor development for each are presented elsewhere. [47][48][49] Briey, PA N endonuclease is one of three proteins in the RNAdependent RNA polymerase complex of the inuenza A virus, along with the polymerase basic protein 1 (PB1) and the polymerase basic protein 2 (PB2). 50 PA N endonuclease contains a dinuclear metal active site, with two Mn 2+ or Mg 2+ cations that promote endonuclease activity.…”
Section: Metallofragment Library Evaluation and Screeningmentioning
confidence: 99%
“…Efforts to apply fragment-based drug discovery (FBDD) to metalloenzymes has produced new libraries of potential MBPs. [3][4][5] However, some new MBPs may possess physiochemical properties that limit their viability for use in drug candidates. 6,7 In medicinal chemistry, functional groups that adversely modulate the pharmacological properties of a drug candidate or introduce clear pharmacological liabilities are oen replaced with alternate functional groups with broadly similar properties referred to as bioisosteres.…”
Section: Introductionmentioning
confidence: 99%